Atea Pharmaceuticals Inc (AVIR)

[tulla236a]

$AVIR
2 trials estimated to end within a week.

Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19
Actual Study Start Date : February 3, 2021
Estimated Primary Completion Date : June 3, 2021
Estimated Study Completion Date : June 3, 2021

Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19)
Actual Study Start Date : May 26, 2020
Estimated Primary Completion Date : March 2021
Estimated Study Completion Date : May 2021